Efficacy News and Research

RSS
Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure

Nanotherapeutics files NanoDTPA IND for treatment of radiation exposure

Trius commences oral torezolid phosphate Phase 3 clinical study for ABSSSI

Trius commences oral torezolid phosphate Phase 3 clinical study for ABSSSI

PCEC coordinates free or low-cost prostate cancer screenings as part of PCAW

PCEC coordinates free or low-cost prostate cancer screenings as part of PCAW

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

RLY5016 potassium binder helps to regulate hyperkalemia in heart failure patients

Latest achievements in brain research and treatment for mental disorders

Latest achievements in brain research and treatment for mental disorders

Study finds bone marrow stem cell therapy improves efficacy in chronic heart failure

Study finds bone marrow stem cell therapy improves efficacy in chronic heart failure

23rd ECNP Press conference on impact of circadian rhythms on human brain

23rd ECNP Press conference on impact of circadian rhythms on human brain

ATOLL study favors enoxaparin over UFH for primary Percutaneous Coronary Intervention

ATOLL study favors enoxaparin over UFH for primary Percutaneous Coronary Intervention

Scientists develop new combined treatment method for skin cancer prevention

Scientists develop new combined treatment method for skin cancer prevention

Researchers find smoked cannabis reduces chronic neuropathic pain

Researchers find smoked cannabis reduces chronic neuropathic pain

Study reveals impact of genetic make-up on response to oral antiplatelet treatment ticagrelor

Study reveals impact of genetic make-up on response to oral antiplatelet treatment ticagrelor

New non-invasive method to diagnose osteoarthritis

New non-invasive method to diagnose osteoarthritis

Nationwide Children's Hospital designated as Wellstone Muscular Dystrophy Cooperative Research Center

Nationwide Children's Hospital designated as Wellstone Muscular Dystrophy Cooperative Research Center

FDA denies accelerated approval of Genentech's trastuzumab-DM1 (T-DM1) BLA for metastatic breast cancer

FDA denies accelerated approval of Genentech's trastuzumab-DM1 (T-DM1) BLA for metastatic breast cancer

Aethlon Medical receives approval for Chronic HCV Infection treatment

Aethlon Medical receives approval for Chronic HCV Infection treatment

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

Lotus Pharmaceuticals initiates R-Bambuterol Clinical Trial I on-schedule

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

Dose-defining Phase IIa trial of CXL-1020 initiated for treating patients with ADHF

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

23rd European College of Neuropsychopharmacology Congress to be held 28 Aug - 1 Sep 2010 in Amsterdam

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

FDA approves Chelsea Therapeutics' Phase II protocol for CH-4051 antifolate in rheumatoid arthritis

Octapharma completes clinical development of Uniplas human pooled plasma

Octapharma completes clinical development of Uniplas human pooled plasma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.